Search Your Queries Related To Trilegal


Trilegal has advised on a spectrum of complex and strategic matters, leveraging its regulatory expertise and network with regulatory healthcare authorities to provide clients pragmatic and solution-oriented litigation and competition advice.

India has a robust pharmaceutical industry comprising a diverse range of players that are significant contributors to the economy. As the sector continues to grow, the government has also been taking steps to streamline regulatory procedures. In 2022, the government released a draft of the New Drugs, Medical Devices and Cosmetics Bill to address the changing requirements of the industry and support technological innovation. The bill proposes a new definition for over-the-counter drugs, manufacturers, clinical trials, medical devices, and more to ensure the quality, safety, efficacy, and performance of new drugs.

Trilegal has developed extensive experience in navigating this complex and consistently evolving regulatory environment in the pharmaceutical industry and is committed to providing clients with innovative and effective legal solutions. Our pharmaceutical practice provides a comprehensive range of legal services. We regularly assist leading pharmaceutical firms, private equity firms and other strategic investors on M&A transactions, joint ventures, business transfers, asset monetisation, brand/IP sales, molecular studies and collaboration agreements, licensing arrangements and contract studies, leverage financing and specific regulatory advice (on clinic trials, medical devices and manufacturing/sale licenses).

Our lawyers have advised on a spectrum of complex and strategic matters, leveraging their regulatory expertise and network with regulatory healthcare authorities to provide clients pragmatic and solution-oriented advice. We have worked with domestic and multinational pharmaceutical and biotech companies, medical device manufacturers, clinical research organisations, healthcare providers, start-ups and more, assisting them with litigation and competition advice. Owing to our extensive experience in the industry, our multi-faceted team of experts is adept at providing exceptional legal representation and strategic guidance that is in sync with the clients’ business goals.

Some of our clients in this sector include –

  • Ajinomoto Bio-Pharma
  • Aventis Pharma
  • Centrient Pharmaceuticals
  • Famy Healthcare Ltd
  • Glenmark Pharmaceuticals
  • GlaxoSmithKline Pharmaceuticals
  • Hikma Pharmaceuticals
  • J.B. Chemicals and Pharmaceuticals
  • Piramal Pharma
  • Sanofi Group
  • Viatris Inc

Related Industries


This page contains general information regarding Trilegal and is not intended as a solicitation or an advertisement of its services or any invitation or inducement of any sort. Nothing contained in this website constitutes legal advice or creation of a lawyer-client relationship. If you have any issues, you must seek legal advice. Trilegal is not liable for the consequences of any action taken by relying on the material/information provided on this website. For more information, please read our terms of use and our privacy policy.

Trilegal - Up Arrow